Pharmaceutical composition for reducing endometriosis
Other
OA: closed
AI-generated summary
A pharmaceutical composition containing a low-dose gestagen with anti-androgenic activity effectively treats endometriosis without negatively affecting bone metabolism or bone density.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Pharmaceutical composition comprises a gestagen with anti-androgenic activity at a daily dosage, which is no more than two times the dosage required to suppress ovulation, together with one more adjuvants/carriers. The composition has lack of negative affect on bone metabolism and bone density during the therapy of endometriosis. An independent claim is included for a kit comprising at least 28 or 30 daily dosage of the composition. - ACTIVITY : Gynecological. - MECHANISM OF ACTION : None given.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-10-14T06:08:39.101224+00:00